[1]
|
The Korean Association for the Study of the Liver (KASL) (2022) KASL Clinical Practice Guidelines for Management of Chronic Hepatitis B. Clinical and Molecular Hepatology, 28, 276-331. https://doi.org/10.3350/cmh.2022.0084
|
[2]
|
Boora, S., Sharma, V., Kaushik, S., Bhupatiraju, A., Singh, S. and Kaushik, S. (2023) Hepatitis B Virus-Induced Hepatocellular Carcinoma: A Persistent Global Problem. Brazilian Journal of Microbiology.
https://doi.org/10.1007/s42770-023-00970-y
|
[3]
|
(2021) Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections. Accountability for the Global Health Sector Strategies 2016-2021: Actions for Impact.
https://apps.who.int/iris/bitstream/handle/10665/342808/9789240030985-eng.pdf
|
[4]
|
Cui, F., Blach, S., Man-zengo Mingiedi, C., et al. (2023) Global Reporting of Progress towards Elimination of Hepatitis B and Hepatitis C. The Lancet Gastroenterology & Hepatology, 8, 332-342.
https://doi.org/10.1016/S2468-1253(22)00386-7
|
[5]
|
Nguyen, M.H., Wong, G., Gane, E., Kao, J.H. and Dusheiko, G. (2020) Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews, 33, e00046-19. https://doi.org/10.1128/CMR.00046-19
|
[6]
|
王贵强, 王福生, 成军, 等. 慢性乙型肝炎防治指南(2015年版) [J]. 中华实验和临床感染病杂志, 2015, 19(5): 1-18.
|
[7]
|
Terrault, N.A., Lok, A.S.F., McMahon, B.J., Chang, K.M., Hwang, J.P., Jonas, M.M., et al. (2018) Update on Prevention, Diagnosis, and Treatment of Chronic Hep-atitis B: AASLD 2018 Hepatitis B Guidance. Hepatology, 67, 1560-1599.
https://doi.org/10.1002/hep.29800
|
[8]
|
Xu, Y., Liu, H., Wang, Y., Hao, R., Li, Z. and Song, H. (2013) The Next Step in Controlling HBV in China. BMJ, 347, f4503-f4503. https://doi.org/10.1136/bmj.f4503
|
[9]
|
(2017) EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology, 67, 370-398. https://doi.org/10.1016/j.jhep.2017.03.021
|
[10]
|
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版) [J]. 中华肝脏病杂志, 2022, 30(12): 1309-1331. https://doi.org/10.3760/cma.j.cn501113-20221204-00607
|
[11]
|
宁会彬, 尚佳. 年龄不应作为ALT正常的慢性HBV感染患者抗病毒治疗的束缚[J]. 中华肝脏病杂志, 2022, 30(11): 1246-1247. https://doi.org/10.3760/cma.j.cn501113-20220321-00128
|
[12]
|
Lin, C., Liao, L., Liu, C., et al. (2007) Hepatitis B Viral Factors in HBeAg-Negative Carriers with Persistently Normal Serum Alanine Aminotransferase Levels. Hepatolo-gy (Baltimore, Md), 45, 1193-1198.
https://doi.org/10.1002/hep.21585
|
[13]
|
宁会彬, 靳慧鸣, 李宽, 彭真, 尚佳. 丙氨酸转氨酶正常的乙型肝炎e抗原阴性慢性乙型肝炎患者的肝脏病理特征及血清学无创诊断模型价值分析[J]. 中华传染病杂志, 2022, 40(12): 729-734.
https://doi.org/10.3760/cma.j.cn311365-20220321-00093
|
[14]
|
刘勇, 邹亚文, 孙嬴, 王雪梅, 余祖江. 谷丙转氨酶持续正常HBeAg阳性慢性HBV感染者肝组织学病变的独立危险因素探讨及无创模型建立[J]. 河南医学研究, 2022(3): 31.
|
[15]
|
Sarin, S.K., Kumar, M., Lau, G.K., Abbas, Z., Chan, H.L., Chen, C.J., et al. (2016) Asian-Pacific Clinical Practice Guidelines on the Management of Hepatitis B: A 2015 Update. Hepatology International, 10, 1-98.
https://doi.org/10.1007/s12072-015-9675-4
|
[16]
|
Liao, B., Wang, Z., Lin, S., Xu, Y., Yi, J., Xu, M., Huang, Z., Zhou, Y., Zhang, F. and Hou, J. (2013) Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALT. PLOS ONE, 8, e78672.
https://doi.org/10.1371/journal.pone.0078672
|
[17]
|
Tan, Y.W., Zhou, X.B., Ye, Y., He, C. and Ge, G.H. (2017) Diagnostic Value of FIB-4, Aspartate Aminotransferase-to-Platelet Ratio Index and Liver Stiffness Measurement in Hep-atitis B Virus-Infected Patients with Persistently Normal Alanine Aminotransferase. World Journal of Gastroenterology, 23, 5746-5754.
https://doi.org/10.3748/wjg.v23.i31.5746
|
[18]
|
Tan, Y., Ye, Y., Zhou, X., Chen, L. and Wen, D. (2015) Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase. PLOS ONE, 10, e0123452. https://doi.org/10.1371/journal.pone.0123452
|
[19]
|
Papatheodoridis, G.V., Manesis, E.K., Manolakopoulos, S., Elefsiniotis, I.S., Goulis, J., Giannousis, J., et al. (2008) Is There a Meaningful Serum Hepatitis B Virus DNA Cutoff Level for Therapeutic Decisions in Hepatitis B e Antigen-Negative Chronic Hepatitis B Virus Infection? Hepatology, 48, 1451-1459. https://doi.org/10.1002/hep.22518
|
[20]
|
Zhang, C., Li, J.W., Wu, Z., Zhao, H. and Wang, G.Q. (2021) Significant Histologic Changes Are Not Rare in Treatment-Naive Hepatitis B Patients with Normal Alanine Aminotrans-ferase Level: A Meta-Analysis. Journal of Clinical and Translational Hepatology, 9, 615-625. https://doi.org/10.14218/JCTH.2020.00136
|
[21]
|
Yoo, J.-J., et al. (2023) Long-Term Prognosis and the Need for Histologic Assessment of Chronic Hepatitis B in the Serological Immune-Tolerant Phase. Clinical and Molecular Hepa-tology, 29, 482-495.
https://doi.org/10.3350/cmh.2022.0322
|
[22]
|
Feng, M., Lei, L., Xu, J., Shi, Y. and Yang, W. (2022) Plate-let-to-Portal Vein Width Ratio and Platelet-to-Spleen Thickness Ratio Can Be Used to Predict Progressive Liver Fibrosis among Patients with HBV Infection with HBeAg- Negativity and a Normal ALT Level. Frontiers in Medicine, 9, Article ID: 837898.
https://doi.org/10.3389/fmed.2022.837898
|
[23]
|
Duan, M., Chi, X., Xiao, H., et al. (2021) High-Normal Alanine Aminotransferase Is an Indicator for Liver Histopathology in HBeAg Negative Chronic Hepatitis B. Hepatology Interna-tional, 15, 318-327.
https://doi.org/10.1007/s12072-021-10153-2
|
[24]
|
Wang, H., Ru, G.Q., Yan, R., Zhou, Y., Wang, M.S. and Cheng, M.J. (2016) Histologic Disease in Chinese Chronic Hepatitis B Patients with Low Viral Loads and Persistently Normal Alanine Aminotransferase Levels. Journal of Clinical Gastroenterology, 50, 790-796. https://doi.org/10.1097/MCG.0000000000000544
|
[25]
|
Assy, N., Beniashvili, Z., Djibre, A., Nasser, G., Gro-sovski, M. and Nseir, W. (2009) Lower Baseline ALT Cut-Off Values and HBV DNA Levels Better Differentiate HBeAg-Chronic Hepatitis B Patients from Inactive Chronic Carriers. World Journal of Gastroenterology, 15, 3025-3031. https://doi.org/10.3748/wjg.15.3025
|
[26]
|
Gui, H.L., Wang, H., Yang, Y.H., Wu, Y.W., Zhou, H.J., Guo, S.M., Lin, L.Y., Wang, L., Cai, W., Chen, R., Guo, Q., Zhou, X.Q., Bao, S.S. and Xie, Q. (2010) Significant Histopathology in Chinese Chronic Hepatitis B Patients with Persistently High-Normal Alanine Aminotransferase. Journal of Viral Hep-atitis, 17, 44-50.
https://doi.org/10.1111/j.1365-2893.2010.01270.x
|
[27]
|
周璇, 李维正, 马文婷, 薛冬英. ALT正常慢性HBV感染者肝组织病理与年龄, ALT和HBV DNA水平相关性研究[J]. 肝脏, 2019, 24(10): 1141-1144.
|
[28]
|
Zoulim, F. and Mason, W.S. (2012) Reasons to Consider Earlier Treatment of Chronic HBV Infections. Gut, 61, 333-336. https://doi.org/10.1136/gutjnl-2011-300937
|
[29]
|
Huang, D., Li, X., Le, M.H., Le, A.K., Yeo, Y.H., Trinh, H.N., et al. (2022) Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis b Patients with Indetermi-nate Phase. Clinical Gastroenterology and Hepatology, 20, 1803-1812.e5. https://doi.org/10.1016/j.cgh.2021.01.019
|
[30]
|
Ren, S., Wang, W., Lu, J., Wang, K., Ma, L., Zheng, Y., Zheng, S. and Chen, X. (2022) Effect of the Change in Antiviral Therapy Indication on Identifying Significant Liver Injury among Chronic Hepatitis B Virus Infections in the Grey Zone. Frontiers in Immunology, 13, Article ID: 1035923. https://doi.org/10.3389/fimmu.2022.1035923
|
[31]
|
中华医学会肝病学分会. 扩大慢性乙型肝炎抗病毒治疗的专家意见[J]. 中华肝脏病杂志, 2022, 30(2): 131-136.
https://doi.org/10.3760/cma.j.cn501113-20220209-00060
|